全球动物模型市场规模、份额、趋势和成长分析报告（2026-2034年）

动物模型市场预计将从 2025 年的 32.4 亿美元成长到 2034 年的 70.8 亿美元，2026 年至 2034 年的复合年增长率为 9.07%。

受药物研发、疾病研究和生物技术领域研究不断深入的推动，全球动物模型市场呈现稳定成长态势。动物模型在临床前试验和理解复杂生物学过程方面发挥着至关重要的作用。製药业研发投入的增加以及慢性病的盛行率上升，都显着促进了市场扩张。

成长要素包括基因工程的进步、对个人化医疗日益增长的需求以及生物医学研究倡议的扩展。基因改造和人源化动物模型的开发提高了研究的准确性和效率。政府和学术界对生命科学研究的资助也进一步促进了市场成长。

预计未来市场将持续成长，主要得益于生物技术和精准医疗领域的创新。伦理考量和法规结构将继续影响研究实践。诸如晶片器官技术等新兴替代方案或许能在不久的将来与动物模型形成互补，但不太可能完全取代动物模型。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球动物模型市场：依应用范围划分

• 市场分析、洞察与预测
• 癌症
• 免疫疾病
• 感染疾病
• 其他的

第五章：全球动物模型市场：依动物种类和范围划分

• 市场分析、洞察与预测
• 老鼠
• 鼠
• 天竺鼠
• 兔子
• 仓鼠
• 其他的

第六章：全球动物模型市场：依最终用途划分

• 市场分析、洞察与预测
• 製药和生物技术公司
• 学术研究机构
• 合约研究机构

第七章：全球动物模型市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Charles River Laboratories
  • The Jackson Laboratory
  • GenOway
  • Taconic Biosciences Inc
  • Janvier Labs
  • Harbour BioMed
  • Crown Bioscience
  • Inotiv
  • Biocytogen
  • BioSpherix Ltd
  • Animal M

The Animal Model Market size is expected to reach USD 7.08 Billion in 2034 from USD 3.24 Billion (2025) growing at a CAGR of 9.07% during 2026-2034.

The Global Animal Model Market has witnessed steady growth due to increasing research in drug development, disease studies, and biotechnology. Animal models play a critical role in preclinical testing and understanding complex biological processes. Rising investments in pharmaceutical R&D and the growing prevalence of chronic diseases have significantly supported market expansion.

Growth drivers include advancements in genetic engineering, increasing demand for personalized medicine, and expanding biomedical research initiatives. The development of transgenic and humanized animal models has enhanced research accuracy and efficiency. Government and academic funding for life sciences research further strengthens market growth.

In the future, the market is expected to grow alongside innovation in biotechnology and precision medicine. Ethical considerations and regulatory frameworks will continue shaping research practices. Emerging alternatives such as organ-on-chip technologies may complement, but not fully replace, animal models in the near term.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application Scope

• Cancer
• Immunological Disease
• Infectious Disease
• Others

By Animal Type Scope

• Mice
• Rat
• Guinea Pigs
• Rabbits
• Hamsters
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic Research Institute
• Contract Research Organization

COMPANIES PROFILED

• Charles River Laboratories, The Jackson Laboratory, genOway, Taconic Biosciences Inc, Janvier Labs, Harbour BioMed, Crown Bioscience, Inotiv, Biocytogen, BioSpherix Ltd, Animal M

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL MODEL MARKET: BY APPLICATION SCOPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application Scope
• 4.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Immunological Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL MODEL MARKET: BY ANIMAL TYPE SCOPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Animal Type Scope
• 5.2. Mice Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Rat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Guinea Pigs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Rabbits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Hamsters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL MODEL MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic Research Institute Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Contract Research Organization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL MODEL MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Application Scope
  • 7.2.2 By Animal Type Scope
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Application Scope
  • 7.3.2 By Animal Type Scope
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Application Scope
  • 7.4.2 By Animal Type Scope
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Application Scope
  • 7.5.2 By Animal Type Scope
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Application Scope
  • 7.6.2 By Animal Type Scope
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ANIMAL MODEL INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Charles River Laboratories
  • 9.2.2 The Jackson Laboratory
  • 9.2.3 GenOway
  • 9.2.4 Taconic Biosciences Inc
  • 9.2.5 Janvier Labs
  • 9.2.6 Harbour BioMed
  • 9.2.7 Crown Bioscience
  • 9.2.8 Inotiv
  • 9.2.9 Biocytogen
  • 9.2.10 BioSpherix Ltd
  • 9.2.11 Animal M